Complicated Intra-abdominal Infections: A Focus on Appendicitis and Diverticulitis

被引:10
|
作者
Spirt, Mitchell J. [1 ]
机构
[1] Univ Calif Los Angeles, Div Gastroenterol, Sch Med, Los Angeles, CA 90067 USA
关键词
complicated intra-abdominal infections; appendicitis; diverticulitis; antimicrobials; fluoroquinolones; CIPROFLOXACIN PLUS METRONIDAZOLE; ROUTINE INTERVAL APPENDECTOMY; INTENSIVE-CARE UNIT; COMPUTED-TOMOGRAPHY; COLONIC DIVERTICULITIS; PERCUTANEOUS DRAINAGE; CLINICAL-FEATURES; DIAGNOSIS; DISEASE; MOXIFLOXACIN;
D O I
10.3810/pgm.2010.01.2098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe abdominal pain is a common complaint encountered by primary care and emergency room physicians. Caused by many conditions, including appendicitis and diverticulitis. severe abdominal pain may be I diagnostic challenge. Although different in many ways, appendicitis and diverticulitis are Caused by obstruction of a blind pouch that leads to inflammation of the Structure and Surrounding tissue. Appendicitis and diverticulitis arc 2 of the most frequently diagnosed Causes of complicated intra-abdominal infections. Combined, appendicitis and diverticulitis comprise > 80% of all community-acquired complicated intra-abdominal inflections. These conditions are serious and require prompt diagnosis and treatment. Because complicated intra-abdominal infections are typically polymicrobial, a wide variety of causative pathogens are identified, including Gram-positive and Gram-negative aerobic and anaerobic microorganisms. Treatment for these disorders often requires surgical and medical management. Although surgical intervention can be the definitive treatment for complicated intra-abdominal infections, successful management of appendicitis and diverticulitis will depend on appropriate selection of antimicrobials and optimal duration of therapy to maximize the coverage of potential causative pathogens and to minimize the development of resistance. Guidelines for empiric treatment of complicated intra-abdominal infections recommend broad-spectrum antimicrobials as monotherapy or in combinations, including standard antimicrobial regimens, such as piperacillin/tazobactam, imipenem/cilastatin, and piperacillin-tazobactam/amoxicillin-clavulanate regimens, and fluoroquinolone-based regimens. This review article compares the presentations and treatments of these common complicated intra-abdominal infections.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 50 条
  • [1] The role of the intra-abdominal view in complicated intra-abdominal infections
    Matti Tolonen
    Ville Sallinen
    Ari Leppäniemi
    Minna Bäcklund
    Panu Mentula
    [J]. World Journal of Emergency Surgery, 14
  • [2] The role of the intra-abdominal view in complicated intra-abdominal infections
    Tolonen, Matti
    Sallinen, Ville
    Leppaniemi, Ari
    Backlund, Minna
    Mentula, Panu
    [J]. WORLD JOURNAL OF EMERGENCY SURGERY, 2019, 14
  • [3] A focus on intra-abdominal infections
    Massimo Sartelli
    [J]. World Journal of Emergency Surgery, 5
  • [4] A focus on intra-abdominal infections
    Sartelli, Massimo
    [J]. WORLD JOURNAL OF EMERGENCY SURGERY, 2010, 5
  • [5] Management of complicated intra-abdominal infections
    Barie, PS
    [J]. JOURNAL OF CHEMOTHERAPY, 1999, 11 (06) : 464 - 477
  • [6] Eravacycline for the treatment of complicated intra-abdominal infections
    Montravers, Philippe
    Zappella, Nathalie
    Tran-Dinh, Alexy
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 851 - 863
  • [7] Eravacycline for the treatment of complicated intra-abdominal infections
    Wang, Hongmei
    Nguyen, Namphi
    Cruz, Christopher
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2021, 8 (04) : 203 - 210
  • [8] Complicated intra-abdominal infections: pathogens, resistance
    Bodmann, K. -F.
    [J]. CHIRURG, 2010, 81 (01): : 38 - 49
  • [9] Measuring outcomes in complicated intra-abdominal infections
    Ahmed, Shadia
    Wilcox, Mark H.
    Kirby, Andrew
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (01) : 1 - 4
  • [10] Eravacycline: A Review in Complicated Intra-Abdominal Infections
    Lesley J. Scott
    [J]. Drugs, 2019, 79 : 315 - 324